1887

Abstract

Recombinant vaccinia viruses (VV) expressing the varicella-zoster virus (VZV) glycoprotein H (gH) or glycoprotein L (gL) were constructed. The 94 kDa gH intermediate glycoprotein was synthesized in cell cultures infected with the VV-gH recombinant, but only coinfection with both recombinants resulted in the synthesis of the fully processed 118 kDa gH molecule. The VV-expressed gH and gL formed a complex that displayed the conformational neutralization epitope detectable by means of human VZV gH-specific monoclonal antibody V3. Formation of this epitope was inhibited by tunicamycin but not by monensin. Simultaneous intraperitoneal inoculation of mice with high doses of both VV-gH and VV-gL viruses resulted in the development of VZV-neutralizing, complement-independent antibodies; these antibodies were not detected in mice infected solely with either the VV-gH or the VV-gL recombinant.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-2-211
1996-02-01
2022-05-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/2/JV0770020211.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-2-211&mimeType=html&fmt=ahah

References

  1. Boyle D. B., Coupar B. E. 1988; A dominant selectable marker for the construction of recombinant poxviruses. Gene 65:123–128
    [Google Scholar]
  2. Davison A. J., Scott J. E. 1986; The complete DNA sequence of varicella-zoster virus. Journal of General Virology 67:1759–1816
    [Google Scholar]
  3. Ecker J. R., Hyman R. W. 1982; Varicella zoster virus DNA exists as two isomers. Proceedings of National Academy of Sciences, USA 79:156–160
    [Google Scholar]
  4. Forghani B., Dupuis K. W., Schmidt N. J. 1984; Varicellazoster viral glycoproteins analyzed with monoclonal antibodies. Journal of Virology 52:55–62
    [Google Scholar]
  5. Forghani B., Ni L., Grose C. 1994; Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199:458–462
    [Google Scholar]
  6. Gompels U. A., Minson A. C. 1986; The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 153:230–247
    [Google Scholar]
  7. Gompels U. A., Carss A. L., Saxby C., Hancock D. C., Forrester A., Minson A. C. 1991; Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H. Journal of Virology 65:2393–2401
    [Google Scholar]
  8. Grose C., Edwards D. P., Friedrichs W. E., Weigle K. A., McGuire W. L. 1983; Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infection and Immunity 40:381–388
    [Google Scholar]
  9. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A. C., Johnson D. C. 1992; A novel herpes simplex virus glycoprotein, gl, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. Journal of Virology 66:2240–2250
    [Google Scholar]
  10. Joklik W. K. 1962; The purification of four strains of poxvirus. Virology 18:9–10
    [Google Scholar]
  11. Kaye J. F., Gompels U. A., Minson A. C. 1992; Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. Journal of General Virology 73:2693–2698
    [Google Scholar]
  12. Keller P. M., Neff B. J., Ellis R. W. 1984; Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology 52:293–297
    [Google Scholar]
  13. Klupp B., Baumeister J., Karger A., Visser N., Mettenleiter T. 1994; Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. Journal of Virology 68:3868–3878
    [Google Scholar]
  14. Kunke D., Broucek J., Kutinová L., Němečková S., Ludvíková V., Strnad I., Kramosil J., Nemcova J., Schramlova J., Simonova V. 1993; Vaccinia virus recombinants co–expressing hepatitis B virus surface and core antigens. Virology 195:132–139
    [Google Scholar]
  15. Kutinová L., Ludvíková V., Simonova V., Otavova M., Kryštofová J., Hainz P., Press M., Kunke D., Vonka V. 1995; Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine 13:487–493
    [Google Scholar]
  16. Liu D. X., Gompels U. A., Foa–Tomasi L., Campadelli–Fiume G. 1993; Human herpesvirus–6 glycoprotein H and L homologs are components of the gplOO complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197:12–22
    [Google Scholar]
  17. Ludvíková V., Kunke D., Hamšíková E., Kutinová L., Vonka V. 1991; Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant. Journal of General Virology 72:1445–1449
    [Google Scholar]
  18. McGeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., Mcnab D., Perry L. J., Scott J. E., Taylor P. 1988; The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:1531–1574
    [Google Scholar]
  19. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
  20. Montalvo E. A., Grose C. 1986; Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology 149:230–241
    [Google Scholar]
  21. Perkus M. E., Panicali D., Mercer S., Paoletti E. 1986; Insertion and deletion mutants of vaccinia virus. Virology 152:285–297
    [Google Scholar]
  22. Schmidt N. J., Lennette E. 1976; Improved yields of cell-free varicella-zoster virus. Infection and Immunity 14:709–715
    [Google Scholar]
  23. Sugano T., Tomiyama T., Matsumoto Y., Sasaki S., Kimura T., Forghani B., Masuho Y. 1991; A human monoclonal antibody against varicella-zoster virus glycoprotein III. Journal of General Virology 722065–2073
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-2-211
Loading
/content/journal/jgv/10.1099/0022-1317-77-2-211
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error